Condition
C3G clinical trials and research
As of November 12, 2026, Find a Trial lists 2 C3G clinical trials that are recruiting, at sites in 23 countries (most in Italy (2), Spain (2), United Kingdom (2)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 23Countries
All recruiting trials (2)
-
ADX-038 treatment for adults with complement-mediated kidney disease.
This trial will test whether ADX-038 is safe and helps adults with complement-mediated kidney diseases such as IgA nephropathy, C3G, and IC-MPGN.
-
Evaluating iptacopan for treating C3 glomerulopathy
This study is testing if a new medication called iptacopan can help people with C3 glomerulopathy improve their kidney function and reduce protein in their urine.
Related topics
Quick answers
How many C3G clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 23 countries. The most sites are in Italy (2 trials), Spain (2 trials), United Kingdom (2 trials), United States (2 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.